EMA Product Specific GL [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2017-07-28 14:40 (2458 d 01:13 ago) – Posting: # 17620
Views: 8,471

Dear all,

a new set of product-specific guidances was adopted by CHMP for public consultation on 22 June (published on 28 July [1–4], 3 August [5–7]). Deadline for comments: 31 October.
  1. Dolutegravir film-coated tablets 10 mg, 25 mg and 50 mg
  2. Dronedarone film-coated tablets 400 mg
  3. Paracetamol oral use, immediate release formulations
  4. Rilpivirine film-coated tablets 25 mg
  5. Dimethyl fumarate gastro-resistant capsules 120 mg and 240 mg
  6. Prasugrel hydrochloride film-coated tablets 5 mg and 10 mg
  7. Tadalafil film-coated tablets 2.5 mg, 5 mg, 10 mg and 20 mg

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
22,988 posts in 4,825 threads, 1,654 registered users;
96 visitors (1 registered, 95 guests [including 6 identified bots]).
Forum time: 15:53 CEST (Europe/Vienna)

The whole purpose of education is
to turn mirrors into windows.    Sydney J. Harris

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5